FrancophonIA/ELRC3.0 huggingface dataset:
English: IntronA (3 MIU TIW) + ribavirin (800 mg)
Croatian: IU triput na tjedan) + ribavirin (800 mg)
English: 3 million IU/0.5 mL
Croatian: 3 milijuna IU/0,5 ml
English: Corresponding dose (million IU) using IntronA 18 million IU/3 mL solution for injection or infusion
Croatian: Odgovarajuća doza (milijuni IU) koja se dobiva primjenom IntronA 18 milijuna IU/3 ml otopine za injekciju ili infuziju
English: Corresponding dose (million IU) using IntronA 25 million IU/2.5 mL solution for injection or infusion
Croatian: Odgovarajuća doza (milijuni IU) koja se dobiva primjenom IntronA 25 milijuna IU/2,5 ml otopine za injekciju ili infuziju
English: Collect necessary items before you begin: - a vial of IntronA solution for injection; - a syringe with an attached needle for subcutaneous injection; - a cleansing swab.
Croatian: Prije nego što počnete, prikupite sve što Vam je potrebno: - bočicu IntronA otopine za injekciju, - štrcaljku s pričvršćenom iglom za potkožnu injekciju, - tupfer za čišćenje.
English: Follicular lymphoma: Adjunctively with chemotherapy, 5 million IU 3 times a week (every other day) injected subcutaneously (under the skin).
Croatian: Folikularni limfom: kao dodatak uz kemoterapiju, 5 milijuna IU, triput na tjedan (svaki drugi dan) supkutanom injekcijom (potkožno).
English: Table 1 Adverse reactions reported during clinical trials or following the marketing use of IntronA alone or in combination with ribavirin
Croatian: Nuspojave prijavljene u kliničkim ispitivanjima ili nakon stavljanja u promet lijeka IntronA, u monoterapiji ili u kombinaciji s ribavirinom Organski sustav
English: Excipients: disodium phosphate anhydrous, sodium dihydrogen phosphate monohydrate, edetate disodium, sodium chloride, m-cresol, polysorbate 80 and water for injections.
Croatian: Pomoćne tvari: natrijev hidrogenfosfat, bezvodni; natrijev dihidrogenfosfat hidrat; dinatrijev edetat; natrijev klorid; m-krezol; polisorbat 80 i voda za injekcije.
English: Turn the vial and the syringe upside down in one hand.
Croatian: Jednom rukom preokrenite bočicu i štrcaljku.
English: Adverse experiences including prolongation of coagulation markers and liver abnormalities Moderate to severe adverse experiences may require modification of the patient's dose regimen, or in some cases, termination of IntronA therapy.
Croatian: Umjereni do teški neželjeni učinci mogu zahtijevati promjenu režima doziranja ili, u nekim slučajevima, prekid liječenja lijekom IntronA.
English: SVR after treatment of chronic HCV with non-pegylated interferon alfa-2b with ribavirin results in long-term clearance of the virus providing resolution of the hepatic infection and clinical 'cure' from chronic HCV.
Croatian: Trajan virološki odgovor nakon liječenja kroničnog hepatitisa C nepegiliranim interferonom alfa-2b i ribavirinom rezultira dugotrajnom uklanjanju virusa, što omogućuje izlječenje infekcije jetre i kliničko „ozdravljenje“ od kroničnog hepatitisa C.
English: Concomitant chemotherapy
Croatian: Istodobna kemoterapija
English: Vertigo, tinnitus Hearing loss, hearing disorder
Croatian: vrtoglavica, tinitus gubitak sluha, poremećaj sluha
English: One vial contains 18 million IU of interferon alfa-2b in 3 mL of solution.
Croatian: Jedna bočica sadrži 18 milijuna IU interferona alfa-2b u 3 ml otopine.
English: Therefore, do not breast-feed an infant if you are taking IntronA.
Croatian: Stoga, nemojte dojiti dijete ako primate IntronA.
English: Collect necessary items before you begin: - a vial of IntronA solution for injection; - a syringe (for example 2 mL); - a needle for the subcutaneous injection (for example 0.4 x 13 mm [27 gauge 0.5 inch]); - a cleansing swab.
Croatian: Prije nego što počnete, prikupite sve što Vam je potrebno: - bočicu IntronA otopine za injekciju - štrcaljku (primjerice od 2 ml) - iglu za potkožnu injekciju (primjerice 0,4 x 13 mm [veličina 27]) - tupfer za čišćenje.
English: Pure red cell aplasia, idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura
Croatian: leukopenija trombocitopenija, limfadenopatija, limfopenija aplastična anemija izolirana aplazija crvene krvne loze, idiopatska trombocitopenična purpura, trombotička trombocitopenična purpura
English: Visually confirm the pushrod has fully advanced and the needle tip is covered.
Croatian: Pregledajte kako biste se uvjerili da je klizni zatvarač došao do kraja i da je vrh igle prekriven.
English: Injection site inflammation, injection site reaction*, fatigue, rigors, pyrexia
Croatian: upala na mjestu injekcije, reakcija na mjestu injekcije*, umor, tresavica, pireksija
English: Discontinuation of IntronA should be considered in patients who develop new or worsening ophthalmological disorders.
Croatian: U bolesnika u kojih se razviju novi ili pogoršaju postojeći oftalmološki poremećaji treba razmotriti obustavu lijeka IntronA.
English: Co-infected patients with advanced cirrhosis receiving HAART may be at increased risk of hepatic decompensation and death.
Croatian: Bolesnici istodobno zaraženi HIV-om s uznapredovanom cirozom jetre koji primaju vrlo djelotvornu antiretrovirusnu terapiju mogu imati povećan rizik od dekompenzacije jetre i smrti.
English: Photosensitivity reaction, maculopapular rash, eczema, acne, skin disorder, nail disorder, skin discolouration, pruritus, dry skin, erythema, bruise, sweating increased
Croatian: alopecija, osip fotosenzitivna reakcija, makulopapularni osip, ekcem, akne, poremećaj kože, promjene na noktima, promjene boje kože, pruritus, suha koža, eritem, modrice, pojačano znojenje
English: The efficacy and safety of IntronA in combination with ribavirin has been studied in children and adolescents who have not been previously treated for chronic hepatitis C.
Croatian: Bolesnici koji prethodno nisu bili liječeni (djeca i adolescenti) Djelotvornost i sigurnost lijeka IntronA u kombinaciji s ribavirinom ispitivane su u djece i adolescenata koji prethodno nisu bili liječeni zbog kroničnog hepatitisa C.
English: Collect necessary items before you begin: - a vial of IntronA solution for injection; - a syringe (for example 1 mL); - a needle for the subcutaneous injection (for example 0.4 x 13 mm [27 gauge 0.5 inch]); - a cleansing swab.
Croatian: Prije nego što počnete, prikupite sve što Vam je potrebno: - bočicu IntronA otopine za injekciju - štrcaljku (primjerice od 1 ml) - iglu za potkožnu injekciju (primjerice 0,4 x 13 mm [veličina 27]) - tupfer za čišćenje.
English: Daily dosing of cynomolgus monkeys with 20 x 10
Croatian: Svakodnevna primjena doza od 20 x 10
English: - if you have hepatitis and have been treated recently with medicines that suppress the immune system (other than short-term treatment with cortisone-type medicine).
Croatian: - ako imate hepatitis i nedavno ste primali lijekove koji potiskuju aktivnost imunološkog sustava
English: Carcinoid tumour: 5 million IU, 3 times a week (every other day) injected subcutaneously (under the skin).
Croatian: Karcinoid: 5 milijuna IU, triput na tjedan (svaki drugi dan) supkutanom injekcijom (potkožno).
English: HOW TO SELF INJECT INTRONA Syringe with an attached needle
Croatian: KAKO DA SI SAMI DATE INJEKCIJU LIJEKA INTRONA Štrcaljka s pričvršćenom iglom
English: Female: amenorrhea, menorrhagia, menstrual disorder, vaginal disorder
Croatian: žene: amenoreja, menoragija, menstrualni poremećaj, poremećaj vagine muškarci: bol u testisima
English: Collect necessary items before you begin: - a vial of IntronA solution for injection; - a 1 mL syringe with an attached needle and a needle protection device (BD SafetyGlide syringe); - a cleansing swab.
Croatian: Prije nego što počnete, prikupite sve što Vam je potrebno: - bočicu IntronA otopine za injekciju, - štrcaljku od 1 ml s pričvršćenom iglom i uređajem za zaštitu igle (štrcaljka BD SafetyGlide), - tupfer za čišćenje.
English: Cardiomyopathy
Croatian: Karcinoid
English: §, optic neuritis, papilloedema, loss of visual acuity or visual field, cottonwool spots
Croatian: §, optički neuritis, edem papile, gubitak oštrine vida ili vidnog polja, pamučasta krvarenja u mrežnici serozna ablacija mrežnice
English: Injection site inflammation, injection site reaction, fatigue, rigors, pyrexia
Croatian: upala na mjestu injekcije, reakcija na mjestu injekcije, umor, tresavica, pireksija
English: IntronA (3 MIU TIW) + ribavirin
Croatian: c μg na tjedan) + ribavirin
English: Retinal haemorrhages
Croatian: Očne nuspojave
English: Dilute prior to intravenous use.
Croatian: Razrijediti prije primjene u venu.
English: Pulmonary conditions
Croatian: Bolesti pluća
English: IntronA 25 million IU/2.5 mL solution for injection or infusion
Croatian: IntronA 25 milijuna IU/2,5 ml otopina za injekciju ili infuziju
English: Common: Very rarely:
Croatian: često: rijetko: vrlo rijetko:
English: Each vial contains 5 million IU in 0.5 mL of solution.
Croatian: Jedna bočica sadrži 5 milijuna IU u 0,5 ml otopine.
English: Ocular adverse events (see section 4.8) including retinal haemorrhages, cotton wool spots, serous retinal detachment, and retinal artery or vein obstruction have been reported in rare instances after treatment with alpha interferons.
Croatian: U rijetkim su slučajevima nakon liječenja alfa interferonima prijavljene očne nuspojave (vidjeti dio 4.8), uključujući retinalna krvarenja, pamučaste eksudate, seroznu ablaciju mrežnice te opstrukciju retinalne arterije ili vene.
English: 18 million IU/3 mL solution for injection or infusion 1 multiple dose vial
Croatian: 18 milijuna IU/3 ml otopina za injekciju ili infuziju 1 višedozna bočica
English: IntronA 5 million IU/0.5 mL solution for injection or infusion
Croatian: IntronA 5 milijuna IU/0,5 ml otopina za injekciju ili infuziju
English: One vial contains 10 million IU of interferon alfa-2b in 1 mL of solution.
Croatian: Jedna bočica sadrži 10 milijuna IU interferona alfa-2b u 1 ml otopine.
English: More significant obtundation and coma, including cases of encephalopathy, have been observed in some patients, usually elderly, treated at higher doses.
Croatian: U nekih bolesnika, obično starijih, liječenih većim dozama, zabilježeni su značajnije suženje svijesti i koma, uključujući i slučajeve encefalopatije.
English: 12 multiple dose vial, 72 injection syringes with attached needle of 1 mL and 144 cleansing swabs
Croatian: 12 višedoznih bočica, 72 štrcaljke za injekciju s pričvršćenom iglom od 1 ml i 144 tupfera za čišćenje
English: IntronA 10 million IU/mL solution for injection or infusion
Croatian: IntronA 10 milijuna IU/ml otopina za injekciju ili infuziju
English: You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can also help provide more information on the safety of this medicine.
Croatian: Nuspojave možete prijaviti izravno putem nacionalnog sustava za prijavu nuspojava: navedenog u Dodatku V.
English: Nervous system disorders Very common:
Croatian: Poremećaji živčanog sustava vrlo često: često:
English: Each vial contains 3 million IU in 0.5 mL of solution.
Croatian: Jedna bočica sadrži 3 milijuna IU u 0,5 ml otopine.
English: If intolerance persists after dose adjustment or if granulocytes decrease to < 250/mm
Croatian: Ako se nepodnošenje lijeka održi i nakon prilagodbe doze ili ako broj granulocita padne na < 250/mm ili ALT/AST porastu na > 10 x iznad gornje granice normale, liječenje interferonom alfa-2b mora se obustaviti.
English: Hairy Cell Leukaemia: 2 million IU/m 2, 3 times a week (every other day) injected subcutaneously (under the skin).
Croatian: Leukemija vlasastih stanica: 2 milijuna IU/m 2, triput na tjedan (svaki drugi dan) supkutanom injekcijom (potkožno).
English: Select the injection site.
Croatian: Odaberite mjesto na tijelu u koje ćete dati injekciju.
English: One vial contains 25 million IU of interferon alfa-2b in 2.5 mL of solution.
Croatian: Jedna bočica sadrži 25 milijuna IU interferona alfa-2b u 2,5 ml otopine.
English: IntronA 3 million IU/0.5 mL solution for injection or infusion
Croatian: IntronA 3 milijuna IU/0,5 ml otopina za injekciju ili infuziju
English: 25 million IU/2.5 mL solution for injection or infusion 1 multiple dose vial
Croatian: 25 milijuna IU/2,5 ml otopina za injekciju ili infuziju 1 višedozna bočica
English: p value pegylated interferon alfa-2b (100 or c µg/week) + ribavirin
Croatian: pvrijednost pegilirani interferon alfa-2b (100 or 150
English: Alopecia, pruritus*, skin dry*, rash*, sweating increased Psoriasis (new or aggravated)
Croatian: alopecija, pruritus*, suha koža*, osip*, pojačano znojenje psorijaza (novonastala ili pogoršanje postojeće) makulopapularni osip, eritematozni osip, ekcem, eritem, poremećaj kože
English: 3 mL of solution (corresponding to 18 MIU) is contained in a multidose vial (type I glass) with a stopper (halobutyl rubber) in a flip-off seal (aluminium) with a bonnet (polypropylene).
Croatian: 3 ml otopine (što odgovara 18 milijuna IU) sadržane u višedoznoj bočici (staklo tipa I), s čepom (halobutilna guma) u (aluminijskom) "flip-off" zatvaraču, s (polipropilenskim) poklopcem.
English: One vial of solution for injection or infusion contains 18 million IU of recombinant interferon alfa-2b produced in E. coli by recombinant DNA technology, in 3 mL of solution.
Croatian: Jedna bočica otopine za injekciju ili infuziju sadrži 18 milijuna IU rekombinantnog interferona alfa-2b, proizvedenog na E. coli tehnologijom rekombinantne DNK, u 3 ml otopine.
English: One vial contains 5 million IU of interferon alfa-2b in 0.5 mL of solution.
Croatian: Jedna bočica sadrži 5 milijuna IU interferona alfa-2b u 0,5 ml otopine.
English: Both subcutaneous and intramuscular administration resulted in bioavailabilities greater than 100 %.
Croatian: Bioraspoloživost je bila veća od 100% i nakon supkutane i nakon intramuskularne primjene.
English: Multiple myeloma: 3 million IU/m 2, 3 times a week (every other day) injected subcutaneously (under the skin).
Croatian: Multipli mijelom: 3 milijuna IU/m 2, triput na tjedan (svaki drugi dan) supkutanom injekcijom
English: Rotate the needle protection device for bevel orientation or scale readability.
Croatian: Okrenite uređaj za zaštitu igle tako da bude poravnat s kosim otvorom vrha igle ili da možete očitati skalu.
English: All patients should have a baseline eye examination.
Croatian: Svi bolesnici trebaju obaviti oftalmološki pregled prije početka liječenja.
English: One vial contains 3 million IU of interferon alfa-2b in 0.5 mL of solution.
Croatian: Jedna bočica sadrži 3 milijuna IU interferona alfa-2b u 0,5 ml otopine.
English: §, malaise, irritability Chest pain, asthenia, oedema, injection site pain
Croatian: razdražljivost bol u grudnom košu, astenija, edem, bol na mjestu injekcije
English: Results from the clinical trial conducted with pegylated interferon alfa-2b and ribavirin In a multicentre trial children and adolescents 3 to 17 years of age with compensated chronic hepatitis C and detectable HCV-RNA were treated with peginterferon alfa-2b 60 g/m2 plus ribavirin
Croatian: U multicentričnom su ispitivanju djeca i adolescenti u dobi od 3 do 17 godina s kompenziranim kroničnim hepatitisom C i mjerljivim HCV-RNK liječeni peginterferonom alfa-2b u dozi od 60 µg/m jedanput na tjedan i ribavirinom u dozi od 15 mg/kg na dan tijekom 24 ili 48 tjedana, ovisno o genotipu HCV-a i početnom virusnom opterećenju.
English: Serous retinal detachment
Croatian: Prijavljivanje nuspojava
English: 3 million IU/0.5 mL solution for injection or infusion 1 single dose vial
Croatian: 3 milijuna IU/0,5 ml otopina za injekciju ili infuziju 1 jednodozna bočica
English: 5 million IU/0.5 mL solution for injection or infusion 1 single dose vial
Croatian: 5 milijuna IU/0,5 ml otopina za injekciju ili infuziju 1 jednodozna bočica
English: Pack of 12 vials, 72 injection syringes of 1 mL, 72 injection needles and 144 cleansing swabs Pack of 12 vials, 72 injection syringes with attached needle and needle protection device of 1 mL and 144 cleansing swabs
Croatian: 12 višedoznih bočica, 72 štrcaljke za injekciju od 1 ml, 72 igle za injekciju i 144 tupfera za čišćenje 12 višedoznih bočica, 72 štrcaljke za injekciju s pričvršćenom iglom i uređajem za zaštitu igle od 1 ml i 144 tupfera za čišćenje
English: IntronA 18 million IU/3 mL solution for injection or infusion Interferon alfa-2b
Croatian: IntronA 18 milijuna IU/3 ml otopina za injekciju ili infuziju interferon alfa-2b
English: Check with your doctor immediately if you have any of these symptoms.
Croatian: Ako razvijete bilo koji od navedenih simptoma, odmah se javite svom liječniku.
English: EU/1/99/127/023 1 multiple dose vial
Croatian: EU/1/99/127/023 1 višedozna bočica
English: 1 mL of solution (corresponding to 10 MIU) is contained in a single dose vial (type I glass) with a stopper (halobutyl rubber) in a flip-off seal (aluminium) with a bonnet (polypropylene).
Croatian: 1 ml otopine (što odgovara 10 milijuna IU) sadržane u jednodoznoj bočici (staklo tipa I), s čepom (halobutilna guma) u (aluminijskom) "flip-off" zatvaraču, s (polipropilenskim) poklopcem.
English: Follicular lymphoma
Croatian: Folikularni limfom
English: §, rash maculopapular, rash erythematous, eczema, erythema, skin disorder Stevens Johnson syndrome, toxic epidermal necrolysis, erythema multiforme
Croatian: Stevens-Johnsonov sindrom, toksična epidermalna nekroliza, multiformni eritem
English: These undesirable effects have also been reported with IntronA alone.
Croatian: Navedene nuspojave također su prijavljene i kada se IntronA primjenjivao kao monoterapija.
English: Pack of 2 vials, 12 injection syringes with attached needle of 1 mL and 24 cleansing swabs Pack of 12 vials
Croatian: 2 višedozne bočice, 12 štrcaljki za injekciju s pričvršćenom iglom od 1 ml i 24 tupfera za čišćenje 12 višedoznih bočica
English: EU/1/99/127/015 1 single dose vial
Croatian: EU/1/99/127/015 1 jednodozna bočica
English: EU/1/99/127/027 1 multiple dose vial
Croatian: EU/1/99/127/027 1 višedozna bočica
English: Patients with pre-existing cardiac abnormalities
Croatian: Bolesnici s postojećim srčanim poremećajima
English: EU/1/99/127/011 1 single dose vial
Croatian: EU/1/99/127/011 1 jednodozna bočica
English: EU/1/99/127/019 1 single dose vial
Croatian: EU/1/99/127/019 1 jednodozna bočica
English: EU/1/99/127/029 2 multiple dose vials
Croatian: EU/1/99/127/029 2 višedozne bočice
English: One vial of solution for injection or infusion contains 10 million IU of recombinant interferon alfa-2b produced in E. coli by recombinant DNA technology, in 1 mL of solution.
Croatian: Jedna bočica otopine za injekciju ili infuziju sadrži 10 milijuna IU rekombinantnog interferona alfa-2b, proizvedenog na E. coli tehnologijom rekombinantne DNK, u 1 ml otopine.
English: 2.5 mL of solution (corresponding to 25 MIU) is contained in a multidose vial (type I glass) with a stopper (halobutyl rubber) in a flip-off seal (aluminium) with a bonnet (polypropylene).
Croatian: 2,5 ml otopine (što odgovara 25 milijuna IU) sadržane u višedoznoj bočici (staklo tipa I), s čepom (halobutilna guma) u (aluminijskom) "flip-off" zatvaraču, s (polipropilenskim) poklopcem.
English: Your doctor has prescribed IntronA specifically for you and your current condition; do not share this medicine with anyone else.
Croatian: Liječnik je propisao IntronA isključivo Vama za liječenje bolesti od koje trenutno bolujete.
English: 1 multiple dose vial, 6 injection syringes with attached needle of 1 mL and 12 cleansing swabs 2 multiple dose vials
Croatian: 1 višedozna bočica, 6 štrcaljki za injekciju s pričvršćenom iglom od 1 ml i 12 tupfera za čišćenje 2 višedozne bočice
English: IntronA contains less than 1 mmol sodium (23 mg) per 2.5 mL, i.e., essentially "sodium-free".
Croatian: IntronA sadrži manje od 1 mmol natrija (23 mg) u 2,5 ml, tj. zanemarive količine natrija.
English: - One mL of solution contains 6 million IU of interferon alfa-2b.
Croatian: - Jedan ml otopine sadrži 6 milijuna IU interferona alfa-2b.
English: 0.5 mL of solution (corresponding to 5 MIU) is contained in a single dose vial (type I glass) with a stopper (halobutyl rubber) in a flip-off seal (aluminium) with a bonnet (polypropylene).
Croatian: 0,5 ml otopine (što odgovara 5 milijuna IU) sadržane u jednodoznoj bočici (staklo tipa I), s čepom (halobutilna guma) u (aluminijskom) "flip-off" zatvaraču, s (polipropilenskim) poklopcem.
English: One vial of solution for injection or infusion contains 25 million IU of recombinant interferon alfa-2b produced in E. coli by recombinant DNA technology, in 2.5 mL of solution.
Croatian: Jedna bočica otopine za injekciju ili infuziju sadrži 25 milijuna IU rekombinantnog interferona alfa-2b, proizvedenog na E. coli tehnologijom rekombinantne DNK, u 2,5 ml otopine.
English: EU/1/99/127/025 2 multiple dose vials
Croatian: EU/1/99/127/025 2 višedozne bočice
English: One mL of solution contains 6 million IU of interferon alfa-2b.
Croatian: Jedan ml otopine sadrži 6 milijuna IU interferona alfa-2b.
English: IntronA contains less than 1 mmol sodium (23 mg) per 0.5 mL, i.e., essentially "sodium-free".
Croatian: IntronA sadrži manje od 1 mmol natrija (23 mg) u 0,5 ml, tj. zanemarive količine natrija.
English: 0.5 mL of solution (corresponding to 3 MIU) is contained in a single dose vial (type I glass) with a stopper (halobutyl rubber) in a flip-off seal (aluminium) with a bonnet (polypropylene).
Croatian: 0,5 ml otopine (što odgovara 3 milijuna IU) sadržane u jednodoznoj bočici (staklo tipa I), s čepom (halobutilna guma) u (aluminijskom) "flip-off" zatvaraču, s (polipropilenskim) poklopcem.
English: Leukopaenia
Croatian: pvrijednost
English: Determine TSH levels if, during the course of IntronA therapy, a patient develops symptoms consistent with possible thyroid dysfunction.
Croatian: Ako bolesnik tijekom primjene lijeka IntronA razvije simptome koji ukazuju na moguću disfunkciju štitne žljezde, mora se odrediti razina TSH-a.
English: Pack of 1 vial, 6 injection syringes of 1 mL, 6 injection needles and 12 cleansing swabs Pack of 1 vial, 6 injection syringes with attached needle and needle protection device of 1 mL and 12 cleansing swabs
Croatian: 1 višedozna bočica, 6 štrcaljki za injekciju od 1 ml, 6 igala za injekciju i 12 tupfera za čišćenje 1 višedozna bočica, 6 štrcaljki za injekciju s pričvršćenom iglom i uređajem za zaštitu igle od 1 ml i 12 tupfera za čišćenje
English: EU/1/99/127/030 12 multiple dose vials
Croatian: EU/1/99/127/030 12 višedoznih bočica
English: 2 multiple dose vials, 12 injection syringes of 1 mL, 12 injection needles and 24 cleansing swabs 2 multiple dose vials, 12 injection syringes with attached needle and needle protection device of 1 mL and 24 cleansing swabs
Croatian: 2 višedozne bočice, 12 štrcaljki za injekciju od 1 ml, 12 igala za injekciju i 24 tupfera za čišćenje 2 višedozne bočice, 12 štrcaljki za injekciju s pričvršćenom iglom i uređajem za zaštitu igle od 1 ml i 24 tupfera za čišćenje
English: EU/1/99/127/026 12 multiple dose vials
Croatian: EU/1/99/127/026 12 višedoznih bočica
English: IntronA contains less than 1 mmol sodium (23 mg) per 1 mL, i.e., essentially "sodium-free".
Croatian: IntronA sadrži manje od 1 mmol natrija (23 mg) u 1 ml, tj. zanemarive količine natrija.
English: One vial of solution for injection or infusion contains 3 million IU of recombinant interferon alfa-2b produced in E. coli by recombinant DNA technology, in 0.5 mL of solution.
Croatian: Jedna bočica otopine za injekciju ili infuziju sadrži 3 milijuna IU rekombinantnog interferona alfa-2b, proizvedenog na E. coli tehnologijom rekombinantne DNK, u 0,5 ml otopine.
English: IntronA 25 million IU/2.5 mL solution for injection or infusion interferon alfa-2b
Croatian: IntronA 25 milijuna IU/2,5 ml otopina za injekciju ili infuziju interferon alfa-2b
English: Pack of 1 vial
Croatian: 1 jednodozna bočica
English: One mL of solution contains 10 million IU of interferon alfa-2b.
Croatian: Jedan ml otopine sadrži 10 milijuna IU interferona alfa-2b.
English: IntronA 10 million IU/mL solution for injection or infusion Interferon alfa-2b
Croatian: IntronA 10 milijuna IU/ml otopina za injekciju ili infuziju interferon alfa-2b
English: IntronA 10 million IU/mL solution for injection or infusion interferon alfa-2b
Croatian: IntronA 10 milijuna IU/ ml otopina za injekciju ili infuziju interferon alfa-2b